Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System-Canada
Not Applicable
Withdrawn
- Conditions
- Chronic Venous Insufficiency
- Interventions
- Device: BlueLeaf Procedure
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Intervene, Inc.
- Registration Number
- NCT05047302
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System - INFINITE-US
Not Applicable
Terminated
- Conditions
- Deep Vein RefluxChronic Venous Insufficiency (CVI)
- Interventions
- Device: BlueLeaf® Endovenous Valve Formation System (BlueLeaf System)
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Intervene, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04225806
- Locations
- 🇺🇸
NYU Langone Medical Center, New York, New York, United States
🇺🇸Sentara Vascular Specialists, Norfolk, Virginia, United States
🇺🇸The Vascular Experts, Darien, Connecticut, United States
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System
Not Applicable
Recruiting
- Conditions
- Chronic Venous Insufficiency
- Interventions
- Device: BlueLeaf System
- First Posted Date
- 2017-07-12
- Last Posted Date
- 2021-09-10
- Lead Sponsor
- Intervene, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03216005
- Locations
- 🇳🇿
Clinical Trials New Zealand Ltd, Hamilton, New Zealand
🇦🇺Prince of Wales, Randwick, New South Wales, Australia
🇦🇺Royal Prince Alfred, Camperdown, New South Wales, Australia
A Feasibility Study of the ReLeaf Catheter System
Not Applicable
Terminated
- Conditions
- Chronic Venous Insufficiency
- Interventions
- Device: ReLeaf
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Intervene, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT02462096
- Locations
- 🇳🇿
Auckland City Hospital, Auckland, New Zealand
© Copyright 2025. All Rights Reserved by MedPath